Cargando…

Germline POT1 Deregulation Can Predispose to Myeloid Malignancies in Childhood

While the shelterin complex guards and coordinates the mechanism of telomere regulation, deregulation of this process is tightly linked to malignant transformation and cancer. Here, we present the novel finding of a germline stop-gain variant (p.Q199*) in the shelterin complex gene POT1, which was i...

Descripción completa

Detalles Bibliográficos
Autores principales: Michler, Pia, Schedel, Anne, Witschas, Martha, Friedrich, Ulrike Anne, Wagener, Rabea, Mehtonen, Juha, Brozou, Triantafyllia, Menzel, Maria, Walter, Carolin, Nabi, Dalileh, Pearce, Glen, Erlacher, Miriam, Göhring, Gudrun, Dugas, Martin, Heinäniemi, Merja, Borkhardt, Arndt, Stölzel, Friedrich, Hauer, Julia, Auer, Franziska
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583981/
https://www.ncbi.nlm.nih.gov/pubmed/34769003
http://dx.doi.org/10.3390/ijms222111572
Descripción
Sumario:While the shelterin complex guards and coordinates the mechanism of telomere regulation, deregulation of this process is tightly linked to malignant transformation and cancer. Here, we present the novel finding of a germline stop-gain variant (p.Q199*) in the shelterin complex gene POT1, which was identified in a child with acute myeloid leukemia. We show that the cells overexpressing the mutated POT1 display increased DNA damage and chromosomal instabilities compared to the wildtype counterpart. Protein and mRNA expression analyses in the primary patient cells further confirm that, physiologically, the variant leads to a nonfunctional POT1 allele in the patient. Subsequent telomere length measurements in the primary cells carrying heterozygous POT1 p.Q199* as well as POT1 knockdown AML cells revealed telomeric elongation as the main functional effect. These results show a connection between POT1 p.Q199* and telomeric dysregulation and highlight POT1 germline deficiency as a predisposition to myeloid malignancies in childhood.